314 related articles for article (PubMed ID: 31292651)
1. Using peripheral blood immune signatures to stratify patients with adult and juvenile inflammatory myopathies.
Wilkinson MGL; Radziszewska A; Wincup C; Ioannou Y; Isenberg DA; Manson JJ; Jury EC
Rheumatology (Oxford); 2020 Jan; 59(1):194-204. PubMed ID: 31292651
[TBL] [Abstract][Full Text] [Related]
2. Ro52/TRIM21-deficient expression and function in different subsets of peripheral blood mononuclear cells is associated with a proinflammatory cytokine response in patients with idiopathic inflammatory myopathies.
Gómez-Martín D; Galindo-Feria AS; Barrera-Vargas A; Merayo-Chalico J; Juárez-Vega G; Torres-Ruiz J; Alcocer-Varela J
Clin Exp Immunol; 2017 Apr; 188(1):154-162. PubMed ID: 27936488
[TBL] [Abstract][Full Text] [Related]
3. Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis.
Srivastava P; Dwivedi S; Misra R
Rheumatol Int; 2016 Jul; 36(7):935-43. PubMed ID: 27193471
[TBL] [Abstract][Full Text] [Related]
4. The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.
Rider LG; Shah M; Mamyrova G; Huber AM; Rice MM; Targoff IN; Miller FW;
Medicine (Baltimore); 2013 Jul; 92(4):223-243. PubMed ID: 23877355
[TBL] [Abstract][Full Text] [Related]
5. Clinical profile of anti-NXP-2 antibody-positive inflammatory myositis and outcome in an Indian population.
Manwatkar A; Padiyar S; Nair A; Jha A; Kumar S; Yadav B; Prakash JAJ; Das JK; Mathew J
Clin Rheumatol; 2023 Dec; 42(12):3289-3297. PubMed ID: 37801141
[TBL] [Abstract][Full Text] [Related]
6. Proinflammatory Histidyl-Transfer RNA Synthetase-Specific CD4+ T Cells in the Blood and Lungs of Patients With Idiopathic Inflammatory Myopathies.
Galindo-Feria AS; Albrecht I; Fernandes-Cerqueira C; Notarnicola A; James EA; Herrath J; Dastmalchi M; Sandalova T; Rönnblom L; Jakobsson PJ; Fathi M; Achour A; Grunewald J; Malmström V; Lundberg IE
Arthritis Rheumatol; 2020 Jan; 72(1):179-191. PubMed ID: 31403245
[TBL] [Abstract][Full Text] [Related]
7. Myositis autoantibodies in a racially diverse population of children with idiopathic inflammatory myopathies.
Perron MM; Vasquez-Canizares N; Tarshish G; Wahezi DM
Pediatr Rheumatol Online J; 2021 Jun; 19(1):92. PubMed ID: 34118936
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells.
Arahata K; Engel AG
Ann Neurol; 1984 Aug; 16(2):193-208. PubMed ID: 6383191
[TBL] [Abstract][Full Text] [Related]
9. High-Dimensional Analysis Reveals Distinct Endotypes in Patients With Idiopathic Inflammatory Myopathies.
Wilfong EM; Bartkowiak T; Vowell KN; Westlake CS; Irish JM; Kendall PL; Crofford LJ; Bonami RH
Front Immunol; 2022; 13():756018. PubMed ID: 35371068
[TBL] [Abstract][Full Text] [Related]
10. [Myositis specific and myositis associated autoantibodies in idiopathic inflammatory myopathies: a serologic study of 46 patients].
Ghirardello A; Zampieri S; Iaccarino L; Tarricone E; Tonello M; Bendo R; Rondinone R; Cozzi F; Doria A
Reumatismo; 2005; 57(1):22-8. PubMed ID: 15776143
[TBL] [Abstract][Full Text] [Related]
11. The clinical phenotypes of the juvenile idiopathic inflammatory myopathies.
Shah M; Mamyrova G; Targoff IN; Huber AM; Malley JD; Rice MM; Miller FW; Rider LG;
Medicine (Baltimore); 2013 Jan; 92(1):25-41. PubMed ID: 23263716
[TBL] [Abstract][Full Text] [Related]
12. Quantitative T cell subsets profile in peripheral blood from patients with idiopathic inflammatory myopathies: tilting the balance towards proinflammatory and pro-apoptotic subsets.
Espinosa-Ortega F; Gómez-Martin D; Santana-De Anda K; Romo-Tena J; Villaseñor-Ovies P; Alcocer-Varela J
Clin Exp Immunol; 2015 Mar; 179(3):520-8. PubMed ID: 25348796
[TBL] [Abstract][Full Text] [Related]
13. Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies.
Hengstman GJ; Brouwer R; Egberts WT; Seelig HP; Jongen PJ; van Venrooij WJ; van Engelen BG
J Neurol; 2002 Jan; 249(1):69-75. PubMed ID: 11954871
[TBL] [Abstract][Full Text] [Related]
14. Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy.
Ichimura Y; Matsushita T; Hamaguchi Y; Kaji K; Hasegawa M; Tanino Y; Inokoshi Y; Kawai K; Kanekura T; Habuchi M; Igarashi A; Sogame R; Hashimoto T; Koga T; Nishino A; Ishiguro N; Sugimoto N; Aoki R; Ando N; Abe T; Kanda T; Kuwana M; Takehara K; Fujimoto M
Ann Rheum Dis; 2012 May; 71(5):710-3. PubMed ID: 22258483
[TBL] [Abstract][Full Text] [Related]
15. Myositis autoantibody profiles and their clinical associations in Greek patients with inflammatory myopathies.
Zampeli E; Venetsanopoulou A; Argyropoulou OD; Mavragani CP; Tektonidou MG; Vlachoyiannopoulos PG; Tzioufas AG; Skopouli FN; Moutsopoulos HM
Clin Rheumatol; 2019 Jan; 38(1):125-132. PubMed ID: 30145635
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-35 in idiopathic inflammatory myopathies.
Mann H; Kryštůfková O; Zámečník J; Háček J; Hulejová H; Filková M; Vencovský J; Šenolt L
Cytokine; 2021 Jan; 137():155350. PubMed ID: 33128920
[TBL] [Abstract][Full Text] [Related]
17. Correlation of clinicoserologic and pathologic classifications of inflammatory myopathies: study of 178 cases and guidelines for diagnosis.
Fernandez C; Bardin N; De Paula AM; Salort-Campana E; Benyamine A; Franques J; Schleinitz N; Weiller PJ; Pouget J; Pellissier JF; Figarella-Branger D
Medicine (Baltimore); 2013 Jan; 92(1):15-24. PubMed ID: 23269233
[TBL] [Abstract][Full Text] [Related]
18. Expression of interferon-regulated genes in juvenile dermatomyositis versus Mendelian autoinflammatory interferonopathies.
Kim H; Gunter-Rahman F; McGrath JA; Lee E; de Jesus AA; Targoff IN; Huang Y; O'Hanlon TP; Tsai WL; Gadina M; Miller FW; Goldbach-Mansky R; Rider LG
Arthritis Res Ther; 2020 Apr; 22(1):69. PubMed ID: 32252809
[TBL] [Abstract][Full Text] [Related]
19. T-cell transcriptomics from peripheral blood highlights differences between polymyositis and dermatomyositis patients.
Houtman M; Ekholm L; Hesselberg E; Chemin K; Malmström V; Reed AM; Lundberg IE; Padyukov L
Arthritis Res Ther; 2018 Aug; 20(1):188. PubMed ID: 30157932
[TBL] [Abstract][Full Text] [Related]
20. Immune mechanisms in polymyositis and dermatomyositis and potential targets for therapy.
Venalis P; Lundberg IE
Rheumatology (Oxford); 2014 Mar; 53(3):397-405. PubMed ID: 23970542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
